Live Breaking News & Updates on Alfred Witjes

Stay updated with breaking news from Alfred witjes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Asieris Presents for the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU

SHANGHAI, Jan. 29, 2024 /PRNewswire/ Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharmaceutical company specializing in discovering, ....

United States , Linda Wu , Alfred Witjes , Asieris Pharmaceuticals Stock Code , Asieris Pharmaceuticals , Stock Code , Clinical Oncology Genitourinary Cancers Symposium , Chief Development Officer , Clin Oncol , Thailand Business ,

Asieris to present a study protocol of APL-1202 in combination with BeiGene's tislelizumab as neoadjuvant therapy（NAC）for muscle invasive bladder cancer (MIBC) patients at 2022 ASCO annual meeting

/PRNewswire/ Asieris Pharmaceuticals (688176.SH), a global innovative biopharma company specializing in discovering and developing innovative drugs for the. ....

United States , Alfred Witjes , Asieris Pharmaceuticals , American Society Of Clinical Oncology , National Medical Products Administration Of China , Drug Administration , Clinical Oncology , Drug Evaluation , National Medical Products Administration , Clin Oncol , Natl Cancer Inst ,